US Stocks
/
PepGen Inc. Share Price
PepGen Inc. Share Price

PepGen Inc. Share Price

NASDAQ: PEPG | Micro Cap
$2.87
-$0.09 (-3.2%) Last updated on 19 Sep, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

PepGen Inc. Stock Performance

Open
$2.94
Prev. Close
$2.96
Circuit Range
N/A
Day Range
$2.84 - $2.94
Year Range
$1.31 - $7.79
Volume
59,120
Average Traded
$2.89

PepGen Inc. Share Price Today

As of 19 September 2026, PepGen Inc.'s share price is $2.87. The stock opened at $2.94, compared to its previous close of $2.96. During today's trading session, PepGen Inc.'s share price traded between $2.84 and $2.94, with an average price of $2.89. Over the past 52 weeks, the stock has recorded a high of $7.79 and a low of $1.31. In terms of performance, PepGen Inc.'s share price has risen by 64.47% over the last six months and is down 37.74% on a year-on-year basis.

PepGen Inc. Share Price Chart

$2.84$2.94
L
Show Current Price
H

PepGen Inc. Stock Fundamentals & Key Indicators

Market Cap
$121.18M
PE Ratio (TTM)
-1.35
Dividend Yield
N/A
EPS (TTM)
$-2.12
Revenue (TTM)
N/A
Return On Equity (TTM)
-60.81%
Profit Margin
N/A
Debt to Equity
0.09
Quarterly Earnings Growth YoY
15.70%

PepGen Inc. Quarterly Profit & Loss

All figures in USD

ParticularsMar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025
RevenueN/AN/AN/AN/AN/AN/A
Net Profit-$18.02M-$28.34M-$21.38M-$30.20M-$23.09M-$18.03M
Net Profit MarginN/AN/AN/AN/AN/AN/A
Income ChangeN/A-57.24%24.53%-41.24%23.56%21.92%

PepGen Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
RevenueN/AN/AN/AN/A
Net Profit-$69.10M-$78.63M-$89.98M-$89.66M
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-13.78%-14.44%0.36%

About PepGen Inc.

PepGen Inc., a clinical-stage biotechnology company, develops oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases in the United States. Its lead product candidates comprise PGN-EDO51, an EDO peptide which is Phase 2 clinical trial to treat duchenne muscular dystrophy (DMD) patients that are amenable to an exon 51-skipping approach; PGN-EDODM1, an EDO peptide-conjugated PMO, which is in Phase 2 clinical trial for the treatment of myotonic dystrophy type 1; and PGN-EDO53, which is in preclinical trial to treat duchenne muscular dystrophy. The company was founded in 2018 and is based in Boston, Massachusetts.

PepGen Inc. Historical Returns

MonthOpenCloseChange %
Sep 2026
$2.98
$2.87
-6.98%
Aug 2026
$1.78
$3.08
+74.01%
Jul 2026
$1.80
$1.77
-1.39%
Jun 2026
$1.47
$1.79
+18.87%
May 2026
$1.65
$1.51
-8.21%
Apr 2026
$1.76
$1.65
-5.73%
Mar 2026
$6.02
$1.75
-71.90%
Feb 2026
$5.15
$6.21
+21.29%
Jan 2026
$6.40
$5.12
-21.59%
Dec 2025
$6.24
$6.53
+1.71%
Nov 2025
$4.70
$6.42
+37.77%
Oct 2025
$5.04
$4.66
+1.08%

PEPG Share Price FAQs

What is PepGen Inc. share price today?

chevron-up
PepGen Inc. share price today is $2.87 as on September 19, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of PepGen Inc. stock?

chevron-up
The 52 week high of PepGen Inc. stock is $7.79, while the 52 week low is $1.31 as of 19 Sep '26.

What is PEPG's market capitalisation today?

chevron-up
PEPG market capitalisation is $121.18M as of September 19, 2026, at 8:35 pm IST.

What is PEPG's net income for the last quarter?

chevron-up
PEPG's net income for the last quarter is -0.02B USD.

What is the 5 year returns of PEPG?

chevron-up
The 5 year returns of PEPG is -74.35% as on 19 Sep '26.

What is the high & low stock price of PEPG today?

chevron-up
PEPG stock price hit a high of $2.94 and low of $2.84 as of 19 Sep '26.

Can I buy PEPG shares in India?

chevron-up
Yes. You can buy PEPG in India by opening an international trading account.